Next, we sought to evaluate the capacity of CIM7 to inhibit CMA and reduce NSCLC tumor growth in vivo as well as the translational potential to inhibit CMA via NCoR1/RARα targeting in NSCLC. The gene discussed is RARA; the disease is neoplasm.